News
Medpage Today on MSN11h
Targeting Novel Immune Checkpoint Shows Promise in Metastatic CRCTargeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback